Waypoint Bio
Engineering cells with AI-powered models
New York, United States · Founded 2021 · $34.5M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- waypointbio.com
- Total Funding
- $34.5M
- Last Round
- $20.0M Series AJun 2026
- Rounds
- 2
About
Waypoint Bio develops AI-designed CAR-T cell therapies for solid tumors using spatial pooled screening and proprietary machine learning. The platform tests thousands of therapy designs in vivo simultaneously, using spatial biology phenotyping and the Wayfinder LLM to rank and optimize cell therapy constructs. Based in New York, the company closed a $20M Series A in 2026.
Summary
Waypoint Bio is an Artificial Intelligence company based in New York, United States, founded in 2021. It has raised $34.5M in total across 2 rounds, most recently a $20.0M Series A round in Jun 2026. Investors include General Catalyst.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...